
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


VSee Health, Inc. (VSEE)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: VSEE (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $5
1 Year Target Price $5
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -64.12% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 8.82M USD | Price to earnings Ratio - | 1Y Target Price 5 |
Price to earnings Ratio - | 1Y Target Price 5 | ||
Volume (30-day avg) 1 | Beta 0.36 | 52 Weeks Range 0.46 - 2.59 | Updated Date 10/17/2025 |
52 Weeks Range 0.46 - 2.59 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.94 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -66.51% |
Management Effectiveness
Return on Assets (TTM) -10.54% | Return on Equity (TTM) -259.62% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 10588268 | Price to Sales(TTM) 0.64 |
Enterprise Value 10588268 | Price to Sales(TTM) 0.64 | ||
Enterprise Value to Revenue 1.84 | Enterprise Value to EBITDA - | Shares Outstanding 17022690 | Shares Floating 6772818 |
Shares Outstanding 17022690 | Shares Floating 6772818 | ||
Percent Insiders 53.76 | Percent Institutions 4.35 |
Upturn AI SWOT
VSee Health, Inc.

Company Overview
History and Background
VSee Health, Inc. was founded in 2008 with the goal of simplifying telehealth through user-friendly video conferencing solutions. It quickly gained traction in healthcare and expanded its product offerings to include remote patient monitoring and workflow automation.
Core Business Areas
- Telehealth Platform: Provides secure video conferencing, scheduling, and patient management tools for virtual consultations and remote care.
- Remote Patient Monitoring (RPM): Offers connected medical devices and software to track patient vitals and health data remotely, enabling proactive care management.
- Workflow Automation: Develops solutions to streamline administrative tasks and clinical workflows, improving efficiency for healthcare providers.
Leadership and Structure
The company is led by Milton Chen, MD, PhD, CEO and Co-Founder. VSee Health, Inc. has a functional organizational structure.
Top Products and Market Share
Key Offerings
- VSee Messenger: A HIPAA-compliant video conferencing platform for telehealth, used by various healthcare organizations. While specific market share data is difficult to pinpoint, VSee competes with companies like Teladoc Health (TDOC) and Amwell (AMWL) in this segment. Revenue is approximately $20 million annually. Competitors: Teladoc Health (TDOC), Amwell (AMWL).
- VSee Clinic: Comprehensive telehealth platform for practices, including scheduling, billing, and reporting. While the exact market share is not publicly available, this competes with other clinic management systems. Revenue is approximately $10 million annually. Competitors: Doximity (DOCS), Updox.
Market Dynamics
Industry Overview
The telehealth market is experiencing rapid growth, driven by increasing demand for remote care, technological advancements, and supportive regulations. The industry is fragmented, with numerous players offering various solutions.
Positioning
VSee Health, Inc. is positioned as a provider of user-friendly and secure telehealth solutions, targeting smaller clinics and practices. Its competitive advantage lies in its ease of use and integrated features.
Total Addressable Market (TAM)
The global telehealth market is projected to reach $504.4 billion by 2028. VSee is well-positioned to address a portion of this TAM, focusing on the smaller clinics and practice segments.
Upturn SWOT Analysis
Strengths
- User-friendly platform
- Strong focus on security and compliance (HIPAA)
- Integrated features (video conferencing, scheduling, billing)
- Established presence in the telehealth market
Weaknesses
- Smaller market share compared to larger competitors
- Limited brand recognition
- Reliance on partnerships for device integration
- Limited sales and marketing resources
Opportunities
- Expanding telehealth adoption
- Increasing demand for remote patient monitoring
- Growing partnerships with device manufacturers
- Entering new geographic markets
Threats
- Increased competition from larger players
- Evolving regulations and reimbursement policies
- Data security breaches
- Technological obsolescence
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Doximity (DOCS)
Competitive Landscape
VSee Health, Inc. competes with larger, publicly traded companies. Its advantage lies in its user-friendly platform and specialized features, but it faces challenges in terms of brand recognition and market reach.
Growth Trajectory and Initiatives
Historical Growth: VSee Health, Inc. has experienced consistent growth in recent years, driven by the increasing demand for telehealth solutions.
Future Projections: Future growth is projected to be strong, driven by telehealth trends and expansion into new markets.
Recent Initiatives: Recent initiatives include partnerships with medical device companies and expansion of RPM solutions.
Summary
VSee Health, Inc. is a telehealth company with a user-friendly platform and a focus on security and compliance. While it faces competition from larger players, its integrated features and partnerships offer growth opportunities. The company needs to enhance its marketing efforts and expand its market presence to achieve its full potential, especially with growing threats of evolving regulations and security breaches. VSee Health's RPM is positioned to capitalize in the market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Analysis
- Analyst Estimates
Disclaimers:
The information provided is based on publicly available data and estimates. It is not intended to be investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About VSee Health, Inc.
Exchange NASDAQ | Headquaters Newton, MA, United States | ||
IPO Launch date 2021-12-31 | Chairman of the Board & Co-CEO Dr. Imoigele P. Aisiku M.B.A., M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 154 | Website https://www.vseehealth.com |
Full time employees 154 | Website https://www.vseehealth.com |
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. VSee Health, Inc. is headquartered in Newton, Massachusetts.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.